# clm_3FF30F20CF7D

subject: AbbVie (/record/abbvie.md)  
predicate: board_member  
value: Robert A. Michael  
valid_from: 2024-07-01  
valid_to: null  
published: 2024-02-20  
recorded: 2026-11-08  
confidence: 0.95  
status: valid  
assertable: true  
superseded_by: null  
last_updated: 2026-11-12  
cite: AsOf. "AbbVie board member: Robert A. Michael", as of 2024-07-01. Claim clm_3FF30F20CF7D, https://asof.is/claim/clm_3FF30F20CF7D, accessed 2026-11-13. Source: https://www.sec.gov/Archives/edgar/data/1551152/000110465924058808/0001104659-24-058808-index.htm.  
checked: 2026-11-12 · its source page states the value and the date, as read by an AI model  

> selected Robert A. Michael to succeed Richard A. Gonzalez as AbbVie’s Chief Executive Officer (CEO), effective July 1, 2024 (the “Effective Date”). Upon the Effective Date, Mr. Michael will become a member of the Board as a Class II director

What https://www.sec.gov/Archives/edgar/data/1551152/000110465924058808/0001104659-24-058808-index.htm says, word for word.

## Sources

- https://www.sec.gov/Archives/edgar/data/1551152/000110465924058808/0001104659-24-058808-index.htm (primary, SEC EDGAR 8-K Item 5.02, published 2024-05-08)
- https://www.sec.gov/Archives/edgar/data/1551152/000110465924025262/0001104659-24-025262-index.htm (primary, SEC EDGAR 8-K Item 5.02, published 2024-02-20)
- https://www.wikidata.org/wiki/Q14662364 (secondary, Wikidata)
- https://www.sec.gov/Archives/edgar/data/1551152/000110465924025262/tm246649d1_ex99-1.htm (primary, published 2024-02-20)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.